Norbert Kraut, Global Head of Cancer Research, Boehringer Ingelheim, shared on X/Twitter:
“2023 has been a year with major advances in precision oncology. A must-read in Cancer Discovery. Precision Oncology: 2023 in Review.”
Source: Norbert Kraut/X